Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with wet AMD (age-related macular degeneration):
- Adults aged 50 or older who have been diagnosed with wet AMD with active abnormal blood vessel growth, and who have never received treatment for it before
For people with healthy eyes (comparison group):
- People who show no signs of retinal disease
- People whose glasses or contact lens prescription is not stronger than +3.00 or weaker than -7.00 diopters (confirm with trial site)
- People who have not had any eye surgery in the last 4 months
- People who do not have a significant cataract that could affect the quality of eye scan images
Who may not be able to join:
- People who are unable to give their informed consent to take part in the trial
- People who have significant kidney disease
- People whose blood pressure is higher than 180/110
- People who have previously had laser treatment on the central part of their retina (macula)
- People who have difficulty keeping their gaze steady during eye scanning (OCT imaging)
- People whose vision is worse than 20/200, even with glasses or contact lenses
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Steven Bailey, MD, Oregon Health and Science University
Phone: 503-494-7398
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measure of choroidal neovascular (CNV) vessel area in mm2; Measure of CNV membrane area in mm2; Measure of CNV length density in mm; Measure of retinal fluid volume in mm3; Measure of drusen area in mm2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.